Zhang, C., Zhu, X., Li, L., Ma, T., Shi, M., Yang, Y., & Fan, Q. (2019). A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. Diabetes Metab Syndr Obes.
Citação norma ChicagoZhang, CongXiao, XinWang Zhu, LuLu Li, TianKui Ma, Mai Shi, Ying Yang, and QiuLing Fan. "A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy By Inhibiting NLRP3 Inflammasome Activation." Diabetes Metab Syndr Obes 2019.
Citação norma MLAZhang, CongXiao, et al. "A Small Molecule Inhibitor MCC950 Ameliorates Kidney Injury in Diabetic Nephropathy By Inhibiting NLRP3 Inflammasome Activation." Diabetes Metab Syndr Obes 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.